Premium
Building a New Biomedical Ecosystem: Pfizer's Centers for Therapeutic Innovation
Author(s) -
Patel A C,
Coyle A J
Publication year - 2013
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2013.89
Subject(s) - general partnership , transparency (behavior) , incentive , clinical pharmacology , business , productivity , knowledge management , management , pharmacology , medicine , political science , economics , computer science , economic growth , finance , law , microeconomics
It is becoming increasingly clear that to significantly enhance research and development productivity and innovation, new external partnerships are essential. Although partnership between academia and industry is not a novel concept, the manner in which such collaborations are designed and implemented has evolved. In 2010, Pfizer took decisive steps to form the Centers for Therapeutic Innovation: a partnership model with academia based on true collaboration, reflected by transparency, shared decision making, and aligned incentives for sustainable innovation. Clinical Pharmacology & Therapeutics (2013); 94 3, 314–316. doi: 10.1038/clpt.2013.89